Laura Beatriz Gomes Brandão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laura Beatriz Gomes Brandão has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Débora Santos Lula Barros
Universidade de Brasília, Brazil
1 shared publication - Gustavo Pereira Calado
Department of Pharmacy, Faculty of Health Sciences University of Brasília Brasília Federal District Brazil
1 shared publication - Letícia Isabella Ferreira Brandão
Department of Pharmacy, Faculty of Health Sciences University of Brasília Brasília Federal District Brazil
1 shared publication - Maria Christina dos Santos Verdam
Department of Pharmacy, Faculty of Health Sciences University of Brasília Brasília Federal District Brazil
1 shared publication - Rafael Santos Santana
Universidade de Brasília
1 shared publication - Rodrigo Fonseca Lima
Universidade de Brasília
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (8)
Evaluation of Interventions and the Impact of Pharmacist Consultations on the Management of Minor Ailments in Brazil
Background: Minor ailments account for a substantial proportion of demands in community pharmacies, particularly in contexts marked by high self‐medication and risk of inappropriate medication use. Objective: To evaluate the adherence of pharmacological and non‐pharmacological interventions to clinical guidelines for minor ailment management and to analyze patient‐reported clinical outcomes. Methods: This observational, quantitative, descriptive study analyzed 227 pharmacist consultations. Interventions were individually reviewed, classified according to the GRADE system, and categorized according to adherence to pharmaceutical care guidelines. One week after the consultation, patients completed a questionnaire on clinical evolution. Results: A total of 332 pharmacological and 549 non‐pharmacological interventions were identified, with guideline adherence rates of 74.4% and 73.4%, respectively. The best performance was observed for Women's Health conditions, whereas gastrointestinal conditions showed the lowest adherence rates and the highest proportion of low‐quality evidence. Among 148 patients followed up, 75.7% reported complete symptom resolution and 24.3% partial improvement. Conclusions: The use of clinical guidelines contributed to more consistent interventions and favorable clinical outcomes, although challenges remain regarding gastrointestinal conditions and the standardization of pharmaceutical practice.
- 9 November 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (8)
Open AccessEvaluation of Interventions and the Impact of Pharmacist Consultations on the Management of Minor Ailments in Brazil
Background: Minor ailments account for a substantial proportion of demands in community pharmacies, particularly in contexts marked by high self‐medication and risk of inappropriate medication use. Objective: To evaluate the adherence of pharmacological and non‐pharmacological interventions to clinical guidelines for minor ailment management and to analyze patient‐reported clinical outcomes. Methods: This observational, quantitative, descriptive study analyzed 227 pharmacist consultations. Interventions were individually reviewed, classified according to the GRADE system, and categorized according to adherence to pharmaceutical care guidelines. One week after the consultation, patients completed a questionnaire on clinical evolution. Results: A total of 332 pharmacological and 549 non‐pharmacological interventions were identified, with guideline adherence rates of 74.4% and 73.4%, respectively. The best performance was observed for Women's Health conditions, whereas gastrointestinal conditions showed the lowest adherence rates and the highest proportion of low‐quality evidence. Among 148 patients followed up, 75.7% reported complete symptom resolution and 24.3% partial improvement. Conclusions: The use of clinical guidelines contributed to more consistent interventions and favorable clinical outcomes, although challenges remain regarding gastrointestinal conditions and the standardization of pharmaceutical practice.